One-minute heart rate recovery and clinical outcomes in transthyretin cardiac amyloidosis: incremental model fit beyond conventional CPET indices
European Heart Journal Open · 03.11.2026 · 6 (6)
DOI: 10.1093/ehjopen/oeag181 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Heart Journal Open, online erschienen am 22.10.2026. Verfasst von Antonio Kösters und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Spitalgasse 23, Vienna 1090, Austria. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bayer, AstraZeneca.
Abstract (Originalsprache)
Aims
To assess the association of 1-min heart rate recovery (HRR1) with clinical outcomes and its incremental contribution to model fit beyond peak VO2 and ventilatory efficiency (VE/VCO2 slope) in transthyretin cardiac amyloidosis (ATTR-CM). Methods and results Consecutive adults with confirmed ATTR-CM undergoing symptom-limited cardiopulmonary exercise testing (CPET) were included in this single-centre observational study. During standardized active recovery at 24 W, HRR1 was defined as peak heart rate minus heart rate exactly 60 s after exercise. Cox proportional-hazards models evaluated all-cause mortality and the composite of mortality or first heart-failure hospitalization. Principal models adjusted for age, sex, peak VO2 and VE/VCO2 slope; NT-proBNP and National Amyloidosis Centre (NAC) stage were examined separately. Of 161 baseline patients, 11 with unverifiable heart-rate measurements were excluded, and exact HRR1 was available in 110. Mortality analysis included 105 patients with 33 deaths; composite-outcome analysis included 107 patients with 51 events. Median HRR1 was 15.5 bpm. In conventional CPET-adjusted models, each 10-bpm greater HRR1 was associated with lower hazards of mortality [hazard ratio (HR) 0.65, 95% confidence interval (CI) 0.44–0.95; P = 0.028] and the composite outcome (HR 0.74, 95% CI 0.57–0.97; P = 0.029). Adding HRR1 improved model fit (likelihood-ratio P = 0.017 and P = 0.021, respectively); apparent C-indices increased from 0.770 to 0.795 for mortality and from 0.695 to 0.699 for the composite outcome. Associations were non-significant after separate adjustment for NT-proBNP or NAC stage.
Conclusion
HRR1 remained associated with outcomes after CPET adjustment and improved model fit. Discrimination gains were modest; value beyond biomarker staging was unproven.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Spitalgasse 23, Vienna 1090, Austria.
- Department of Population Health Sciences, Bristol Medical School, University of Bristol, Oakfield House, Oakfield Grove, Bristol BS8 2BN, United Kingdom.
- Galen Research Ltd, Koba, 100 Barbirolli Square, Manchester M2 3BD, United Kingdom.
- Department of Clinical Pharmacology, Medical University of Vienna, Spitalgasse 23, Vienna 1090, Austria.
ORCID-Profile: Antonio Kösters, Mahshid Eslami, Roza Badr Eslam
Förderung
- Bayer
- AstraZeneca
Zitieren
APA
Kösters, A., Ermolaev, N., Eslami, M., Lichtblau, L., Seilinger, L., Pahr, S., Grzeda, M., & Badr Eslam, R. (2026). One-minute heart rate recovery and clinical outcomes in transthyretin cardiac amyloidosis: incremental model fit beyond conventional CPET indices. European Heart Journal Open, 6(6). https://doi.org/10.1093/ehjopen/oeag181
Vancouver
Kösters A, Ermolaev N, Eslami M, Lichtblau L, Seilinger L, Pahr S, et al. One-minute heart rate recovery and clinical outcomes in transthyretin cardiac amyloidosis: incremental model fit beyond conventional CPET indices. European Heart Journal Open. 2026;6(6). doi:10.1093/ehjopen/oeag181
BibTeX
@article{Ksters2026,
author = {Kösters, Antonio and Ermolaev, Nikita and Eslami, Mahshid and Lichtblau, Leonhard and Seilinger, Lisa and Pahr, Stefanie and Grzeda, Mariusz and Badr Eslam, Roza},
title = {One-minute heart rate recovery and clinical outcomes in transthyretin cardiac amyloidosis: incremental model fit beyond conventional CPET indices},
journal = {European Heart Journal Open},
year = {2026},
volume = {6},
number = {6},
doi = {10.1093/ehjopen/oeag181}
}
EUVIMED